Novo Nordisk’s Ozempic Gets FDA Approval as Kidney-Disease Treatment
Ozempic, or semaglutide, can now be used to reduce the risk of worsening kidney disease or kidney failure in adults with type ...
US FDA approves Novo Nordisk's Ozempic to reduce diabetic kidney disease progression
Novo Nordisk said on Tuesday the U.S. FDA has approved its blockbuster drug Ozempic to lower the risk of progression of ...
Novo’s Ozempic Notches Approval for Kidney Disease, Widening Use
Novo Nordisk A/S’s blockbuster Ozempic won US approval to treat chronic kidney disease in patients who also have type 2 ...
Hosted on MSN12h
Novo Nordisk shares surge on results of new obesity drug trial
Novo Nordisk announced positive trial results for its next-generation obesity drug, leading to a 7.13% surge in its share ...
The New York Times3d
New York Times - Top Stories
Israel’s Cease-Fires in Lebanon and Gaza Appear Fragile Israeli forces killed at least 22 people and injured dozens more in southern Lebanon on Sunday, Lebanese officials said. In Gaza, Israel ...
The New York Times2d
New York Times - Top Stories
Stocks Sink as Investors Worry About China’s A.I. Advances A jolt of panic hit technology stocks on Monday, with investors rattled by fears that A.I. advances by Chinese upstarts could threaten ...